[Progress with management of hereditary angioedema]

Area of Science:

• Immunology
• Genetics
• Pharmacology

Background:

• Hereditary angioedema (HAE) is a rare genetic disorder.
• It results from a deficiency in C1 inhibitor (C1 INH), leading to excess bradykinin production.
• This causes recurrent, unpredictable swelling attacks in various body parts.

Purpose of the Study:

• To summarize the pathophysiology, clinical presentation, and management of HAE.
• To emphasize the importance of accurate diagnosis and differentiation from other angioedema types.
• To highlight the benefits of appropriate HAE treatment on patient outcomes and quality of life.

Main Methods:

• Review of existing literature on HAE.
• Analysis of clinical manifestations and diagnostic criteria.
• Discussion of current and emerging treatment strategies for HAE.

Main Results:

• HAE attacks can affect the skin, gastrointestinal tract, and airway, potentially causing life-threatening laryngeal edema.
• Accurate diagnosis is crucial for effective management.
• Appropriate treatment, including medications to prevent and treat attacks, significantly reduces attack frequency and severity.

Conclusions:

• Effective management of HAE can lower the risk of mortality from laryngeal edema.
• Timely and appropriate treatment improves patients' quality of life, enabling regular participation in daily activities.
• Continued research and specialist care are vital for optimizing HAE patient outcomes.